299 articles
Steven Quay, Chairman of the Board and CEO of Atossa Therapeutics, a company focused on preventing breast cancer in at-risk women and treating breast ca...
Arun Krishna, VP, Head of Lung Cancer Franchise, US Oncology Business Unit at AstraZeneca discusses the positive results from the FLAURA2 Phase III tria...
Paul Limburg, Chief Medical Officer, Screening at Exact Sciences discusses recent research that revealed countless reasons why 45-year-olds in the U.S.
Erin Crane, MD, MPH, gynecologic oncologist with the Atrium Health Levine Cancer Institute and Bobbie, an ovarian cancer patient discuss the prevalenc...
Jeremy Abramson, Director of the Lymphoma Program and the Jon and Jo Ann Hagler Chair in Lymphoma at the Massachusetts General Hospital Cancer Center an...
Returning guest, Sylvie Beljanski, Founder and Executive Vice President of the Beljanski Foundation and a renowned expert in the field of natural approa...
Nicholas Robert, CMO of Ontada, discusses new research that examines potential factors that may impact care and outcomes for affected communities with a...
Mark Stadler, CEO of AccessHope discusses cancer care and why access to the best cancer facilities is out of reach for the majority of Americans, partic...
Ahsan Arozullah, MD, MPH, Senior Vice President, Head of Oncology Development at Astellas discusses the company's presence at the 2023 American Soci...
Joe Ferra, Interim CEO and CFO of Elevation Oncology discusses the company's development of an antibody-drug conjugate (ADC) that targets Claudin18.2, a...